Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors
Clinical trial NCT00263783 · COMPLETED
Trial details
- NCT number
- NCT00263783
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Primary completion
- 2002-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.